GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List

Latest Data & Signals Issued

Signal Type Signal Value Data
Score 0.000 79 days ( 0 % )
Last Price $0.000001 0 %
High/ Low $0.000001 - $0.000001 0%
Chg 7 Days N/A $0.000001 $0.000001
Chg 30 Days N/A $0.000001 $0.000001
Chg 12 mos -100.00 % $0.0790 $0.000001
Trend - 3 mos N/A Width: 0.00000000 %
Trend - 12 mos -83.61 % Width: 130.28 %
Pred. range - 3 mos $0.000001 - $0.000001 0 % - 0 %
Pred. range - 12 mos N/A - $0.0022 -100.00 % - 218,358.64 %
Short MA avg 3 mos Sell 0000-00-00 - N/A days
Long MA avg 3 mos Sell 0000-00-00 - N/A days
Short/Long MA avg 3 mos Sell 0000-00-00 - N/A days
Short MA avg 12 mos Sell 2021-12-17 - 112 days
Long MA avg 12 mos Sell 2021-06-11 - 244 days
Short/Long MA avg 12 mos Sell 2021-06-14 - 243 days
Pivot Short Buy 2022-05-26 - 2 days
Bollinger Sell 0000-00-00 - N/A days
MACD N/A No Dates Stored For This Signal
Click to get the best stock tips daily for free!

About Anthera Pharmaceuticals

Anthera Pharmaceuticals Anthera Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of medicines for patients with unmet medical needs. It develops Sollpura, a non-porcine investigational pancreatic enzyme replacement therapy that is in Phase III clinical trial for the treatment of patients with exocrine pancreatic insufficiency; and Blisibimod, which is in Phase II clinical trial for the treatment of B-cell mediated auto... ANTH Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT